Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1989 Jul;80(7):655–661. doi: 10.1111/j.1349-7006.1989.tb01693.x

Identification of a Human T Cell Clone with the Cytotoxic T Lymphocyte and Natural Killer‐like Cytotoxic Function against Autologous Mammary Carcinoma and K562 Line

Takashi Sato 1, Maraoru Okubo 2, Yoshimasa Wada 2, Noriyuki Sato 2,✉, Kokichi Kikuchi 2
PMCID: PMC5917817  PMID: 2507488

Abstract

Pleural exudative lymphocytes (PLED from a 60‐year‐old female patient showed high cytotoxicity against the autologous mammary tumor line, HMC‐2, and NK‐susceptible K562 cells, although PLEL demonstrated only weak cytotoxic potentials against several allogeneic tumor lines. We successfully obtained seven cytotoxic T cell clones from PLEL bulk populations, and assessed the possibility that these lymphocytes are simply natural killer (NK)‐like cells or have the dual cytotoxic activity of cytotoxic T lymphocytes (CTL) and NK‐like cells. These clones, designated as TcHMC‐2, showed strong cytotoxicity against both HMC‐2 and K562 cells. In contrast, allogeneic human peripheral blood‐derived NK cells could not kill HMC‐2 targets. Furthermore, a blocking study of TcHMC‐2 cytotoxicity using monoclonal antibodies against CD3, CD8 and human MHC class I products showed that all of these antigen molecules were involved in the cytotoxicity of TcHMC.2 clone against autologous HMC‐2 cells, indicating MHC class I recognitive cytotoxicity. These data indicate that the TcHMC‐2 clone may have dual cytotoxicity with CTL‐ and NK‐like activity against autologous HMC‐2 mammary tumor and K562 cells, respectively.

Keywords: Human cytotoxic T lymphocyte clone, Natural killer clone, Autologous tumor

Full Text

The Full Text of this article is available as a PDF (454.9 KB).

REFERENCES

  • 1. ) Old , L. J.Cancer immunology: the search for the specificity — G.H.A. Clowes Memorial Lecture . Cancer Res. , 41 , 361 – 375 ( 1981. ). [PubMed] [Google Scholar]
  • 2. ) Morgan , D. A. , Ruscetti , F. W , and Gallo , R.Selective in vitro growth of T lymphocytes from normal human bone marrows . Science , 193 , 1007 – 1008 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Hercend , T. and Schmidt , R. E.Characteristics and uses of natural killer cells . Immunol. Today , 9 , 291 – 293 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Trimble , W. S. , Johnson , P. W. , Hozumi , N. and Roder , J. C.Inducible cellular transformation by a methallo‐thionein‐ras hybrid oncogene leads to natural killer cell susceptibility . Nature , 321 , 782 – 784 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Herberman , R. B. , Reynolds , C. W. and Ortaldo , J. R.Mechanism of cytotoxicity by natural killer (NK) cells . Ann. Rev. Immunol , 4 , 651 – 680 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Grimm , E. A. , Mazumder , A. , Zhang , H. Z. and Roenberg , S. A.Lymphokine‐activated killer cell phenomenon. Lysis of natural killer‐resistant fresh solid tumor cells by interleukin 2‐activated autologous human peripheral blood lymphocytes. / . Exp. Med. , 155 , 1823 – 1841 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Sato , T. , Sato , N. , Takahashi , S. , Koshiba , H , and Kikuchi , K.Specific cytotoxicity of a long term cultured T cell clone on human autologous mammary cancer cells . Cancer Res. , 46 , 4384 – 4389 ( 1986. ). [PubMed] [Google Scholar]
  • 8. ) Sato , T. , Sato , N. , Takahashi , S. , Okubo , M. , Yagihashi , A. , Torigoe , T. , Takahashi , N. , Okazaki , M. , Asaishi , K. and Kikuchi , K.Characterization of n‐butanol solubilized breast tumor specific antigens recognized by a human autologous cytotoxic T cell clone . Cancer Res. , 48 , 3892 – 3897 ( 1988. ). [PubMed] [Google Scholar]
  • 9. ) Moretta , A. , Pantaleo , G. , Mingari , M. C. , Moretta , L. and Cerottini , J. C.Clonal heterogeneity in the requirement for T3, T4 and T8 molecules in human cytotoxic lymphocyte function . J. Exp. Med. , 159 , 921 – 934 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Hercend , T. , Reinherz , E. L. , Meuer , S. , Schlossman , S. F. and Ritz , J.Phenotypic and functional heterogeneity of human cloned natural killer cell lines . Nature , 301 , 158 – 160 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) David , V. , Bourge , J. F. , Guglielmi , P. , Mahul , D. M. , Degos , L. and Bensussan , A.Human T cell clones use a CD3‐associated surface antigen recognition structure to exhibit both NK‐like and allogeneic cytotoxic reactivity . J, Immunol , 138 , 2831 – 2836 ( 1987. ). [PubMed] [Google Scholar]
  • 12. ) Fast , L. D. , Hansen , J. A. and Newman , W.Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody‐dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytotoxic lymphocytes (CTL) . J. Immunol , 127 , 448 – 454 ( 1982. ). [PubMed] [Google Scholar]
  • 13. ) Moingeon , P. , Ythier , A. , Goubin , G. , Faure , F. , Nowill , A. , Demon , L. , Rainaud , M. , Forestier , F. , Daifors , F. , Bohuon , C. and Hercend , T.A unique T‐cell receptor complex expressed on human fetal lymphocytes displaying natural‐killer‐like activity . Nature , 323 , 638 – 640 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Sato , T. , Sato , N. , Takahashi , S. , Okubo , M. , Yagihashi , A. , Okazaki , A. , Okazaki , Y. , Toda , K. , Horata , K. , Okazaki , M. , Asaishi , K. , Hayasaka , H. and Kikuchi , K.Characterization of two new cancer cell line's derived from human breast tumor . Tumor Res. , 22 , 27 – 39 ( 1987. ). [Google Scholar]
  • 15. ) Lieber , M. , Mazzetta , J. , Nelson‐Rees , W. , Kaplan , M. and Tadaro , G.Establishment of a continuous tumor cell line (PANC‐1) from a human carcinoma of the exocrine pancreas . Int. J. Cancer , 15 , 741 – 747 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Akagi , T. and Kimoto , T.Establishment and characteristics of a human pancreatic cancer cell line (HGC‐25) . Acta Pathol. Jpn. , 27 , 51 – 58 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Sato , T. , Sato , N. , Takahashi , S. , Okubo , M. , Yagihashi , A. , Koshiba , H. , Usui , T. , Katsuramaki , T. , Yamada , T. , Hirata , K. , Shiramatsu , K. , Hayasaka , H. , and Kikuchi , K.Establishment and characterization of new cell lines derived from human pancreatic cancers . Tumor Res. , 21 , 9 – 19 ( 1986. ). [Google Scholar]
  • 18. ) Engel , L. W. , Young , N. A. , Tralka , T. S. , Lippman , M. E. , O'Brien , S. J. and Joyce , M. J.Establishment and characterization of three new continuous cell lines derived from human breast carcinomas . Cancer Res. , 38 , 3352 – 3364 ( 1978. ). [PubMed] [Google Scholar]
  • 19. ) Gutierrez , C. , Bernabe , R. R. , Vega , J. and Kreisler , M.Purification of human T and B cells by a discontinuous density gradient of Percoll . J. Immunol Methods , 29 , 57 – 63 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Tarkkanen , J. , Saksela , E. and Lanier , L. L.Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell . J. Immunol. , 137 , 2428 – 2433 ( 1986. ). [PubMed] [Google Scholar]
  • 21. ) Vose , B. M. and Bonnard , G. D.Specific cytotoxicity against autologous tumor and proliferative responses of human lymphocytes grown in interleukin 2 . Int. J, Cancer , 29 , 33 – 39 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Vose , B. M. , van ky , F. , Fopp , M. and Klein , E.Restricted autologous lymphocytotoxicity in lung neoplasia . Br. J. Cancer , 38 , 375 – 381 ( 1978. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) van ky , F. T. , Vose , B. M. and Klein , E.Human tumor‐lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte mediated cytotoxicity . J. Natl. Cancer Inst. , 62 , 1407 – 1413 ( 1979. ). [PubMed] [Google Scholar]
  • 24. ) Vanky , F. T. , Argov , S. and Klein , E.Tumor biopsy cells participating in systems in which cytotoxicity of lymphocytes is generated. Autologous and allogeneic studies . Int. J. Cancer , 27 , 273 – 280 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Fishwild , D. M. , Benike , C. J. and Engleman , E. G.Activation of HLA‐restricted EBV‐specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines . J. Immunol. , 140 , 1994 – 1998 ( 1988. ). [PubMed] [Google Scholar]
  • 26. ) de Vries , J. E. and Spitz , H.Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells . J. Immunol. , 132 , 510 – 519 ( 1984. ). [PubMed] [Google Scholar]
  • 27. ) Yssel , H. , Spitz , H. and De Vries , J. E.A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells . J. Exp. Med. , 160 , 239 – 254 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Biassoni , R. , Ferrini , S. , Prigione , I. , Moretta , A. , Long , E. O.CDS‐negative lymphokine‐activated cytotoxic cells express the CD3 gene . J. Immunol. , 140 , 1685 – 1689 ( 1988. ). [PubMed] [Google Scholar]
  • 29. ) Kiyotaki , M. , Solomon , K. R. and Letvin , N. L.Herpes ateles immortalizes in vitro CD3+ CD4+ CD8+ marmoset lymphocyte with NK function . J. Immunol. , 140 , 730 – 736 ( 1988. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES